Columbia Care Inc. CCHWF announced a collaboration Thursday with the pharma manufacturer IPS Specials.
The agreement will see Columbia Care’s BeneCeed CBD tablets imported into the United Kingdom for a clinical study.
- Massive Demand & Disruptive Potential – Boxabl has received interest for over 190,000 homes, positioning itself as a major disruptor in the housing market.
- Revolutionary Manufacturing Approach – Inspired by Henry Ford’s assembly line, Boxabl’s foldable tiny homes are designed for high-efficiency production, making homeownership more accessible.
- Affordable Investment Opportunity – With homes priced at $60,000, Boxabl is raising $1 billion to scale production, offering investors a chance to own a stake in its growth.
Why It Matters
The agreement is the first step in Columbia Care's efforts to hold global clinical trials using its cannabis, the company said.
BeneCeed will become the first approved cannabinoid investigational medicinal product imported from the U.S. by the U.K.’s Medicines and Healthcare products Regulatory Agency.
BeneCeed would be used in an examination of a late-stage Phase 2b trial.
Rosemary Mazanet, Columbia Care’s chief scientific officer, touched on the importance of the news in a statement.
“I am proud that we are now raising the bar once more with our funding and independent research partners as we move closer to reaching this momentous milestone for our company.”
IPS Specials has nearly two decades of experience facilitating the import of investigational medicinal products, Mazanet said. Columbia Care is also working with Grow Biotech, "a specialist in navigating challenging regulatory frameworks across the world," to coordinate the effort, she said.
Columbia Care's stock was trading down 1.27% at $4.75 at the time of publication Thursday.
Related Links:
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving—don’t get left behind!
Curious about what’s next for the industry and how to stay ahead in today’s competitive market?
Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.
Secure your spot now before prices go up—this is where the biggest deals and connections happen!
